CTOs on the Move

Milestone Centers

www.aemhmr.org

 
Milestone Centers Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Milestone Centers Inc. is based in Pittsburgh, PA. You can find more information on Milestone Centers Inc. at www.aemhmr.org
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.aemhmr.org
  • 600 Ross Ave
    Pittsburgh, PA USA 15221
  • Phone: 412.371.7391

Executives

Name Title Contact Details

Similar Companies

Saint Francis Health Care Ctr

Saint Francis Health Care Ctr is a Green Springs, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical University of South Carolina Health

The Medical University of South Carolina (MUSC) is a public institution of higher learning the purpose of which is to preserve and optimize human life in South Carolina and beyond. The university provides an interprofessional environment for learning and discovery through education of health care professionals and biomedical scientists, research in the health sciences and provision of comprehensive health care.

Intrexon

Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.

Marimed Foundation

Marimed Foundation is a Kaneohe, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.